MPM BioVentures 2014 LLC's Net Worth

$0

Estimate Recalculated Jun 18, 2025 08:33PM EST

Who is MPM BioVentures 2014 LLC

MPM BioVentures 2014 LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include iTeos Therapeutics, Inc., Entrada Therapeutics, Inc., Repare Therapeutics Inc., Harpoon Therapeutics, Inc., TCR2 THERAPEUTICS INC., Werewolf Therapeutics, Inc., and Oncorus, Inc..

SEC CIK

MPM BioVentures 2014 LLC's CIK is 0001765021

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Entrada Therapeutics, Inc.

Investor
Updated Nov 04, 2021
Form 4
-85.86%
-26.88M
$20.00
Nov 04, 2021
4.43M
Buy-Options
Nov 02
Form 3
Oct 28, 2021
Showing 2 results

Harpoon Therapeutics, Inc.

Investor
Updated Apr 15, 2021
Form 4
-0.14%
-4.67K
$20.16
-$94.08K
Apr 15, 2021
3.22M
Sale
ScheduledApr 13 - Apr 15
Form 4
-0.40%
-12.80K
$23.15
-$296.26K
Apr 13, 2021
3.23M
Sale
ScheduledApr 09 - Apr 12
Form 4
-5.35%
-183.05K
$20.00
-$3.66M
Feb 12, 2021
7.14M
Sale
ScheduledFeb 10
Form 4
-2.61%
-91.70K
$20.06
-$1.84M
Feb 09, 2021
7.32M
Sale
ScheduledFeb 05 - Feb 09
Form 4
-3.30%
-120.07K
$20.22
-$2.43M
Feb 04, 2021
7.41M
Sale
ScheduledFeb 02 - Feb 04
Form 4
-16.56%
-721.19K
$20.02
-$14.44M
Jan 27, 2021
7.53M
Sale
ScheduledJan 25 - Jan 27
Form 4
-3.76%
-170.10K
$22.51
Jan 22, 2021
8.25M
Sale
ScheduledJan 20 - Jan 22
Form 4
5.81%
248.48K
$9.58
-$21.34K
Feb 14, 2019
4.52M
Purchase
Feb 12
Form 3
Feb 07, 2019
322.06K
Showing 9 results

iTeos Therapeutics, Inc.

Investor
Updated Jan 06, 2022
Form 4
-5.08%
-146.69K
$42.58
-$6.25M
Jan 06, 2022
2.74M
Sale
Jan 04 - Jan 05
Form 4
-1.70%
-49.83K
$33.73
-$1.68M
Dec 07, 2021
2.89M
Sale
ScheduledDec 03 - Dec 07
Form 4
-1.40%
-83.52K
$34.63
-$2.88M
Dec 02, 2021
5.88M
Sale
ScheduledNov 30 - Dec 02
Form 4
-0.76%
-23.05K
$35.18
-$810.77K
Nov 30, 2021
3.02M
Sale
ScheduledNov 26 - Nov 29
Form 4
-2.97%
-93.13K
$36.61
-$2.84M
Nov 24, 2021
3.04M
Sale
ScheduledNov 17 - Nov 24
Form 4
-0.54%
-17.10K
$27.45
-$469.31K
Oct 18, 2021
3.13M
Sale
ScheduledOct 15 - Oct 18
Form 4
-1.77%
-56.77K
$27.21
-$1.54M
Oct 14, 2021
3.15M
Sale
ScheduledOct 12 - Oct 14
Form 4
-1.59%
-51.99K
$27.23
-$1.42M
Oct 12, 2021
3.21M
Sale
ScheduledOct 07 - Oct 11
Form 4
-0.84%
-27.57K
$27.05
-$745.52K
Oct 05, 2021
3.26M
Sale
ScheduledOct 01 - Oct 04
Form 4
-0.65%
-21.51K
$27.00
-$580.66K
Sep 30, 2021
3.29M
Sale
ScheduledSep 28 - Sep 30
Form 4
-1.59%
-53.47K
$27.76
-$1.48M
Sep 27, 2021
3.31M
Sale
ScheduledSep 23 - Sep 27
Form 4
-1.00%
-33.93K
$27.50
-$933.03K
Sep 23, 2021
3.36M
Sale
ScheduledSep 21 - Sep 22
Form 4
-2.62%
-91.25K
$28.38
-$2.59M
Sep 20, 2021
3.40M
Sale
ScheduledSep 16 - Sep 20
Form 4
-1.29%
-45.66K
$27.70
-$1.26M
Sep 16, 2021
3.49M
Sale
ScheduledSep 14 - Sep 15
Form 4
-1.60%
-57.64K
$28.32
-$1.63M
Sep 13, 2021
3.53M
Sale
ScheduledSep 09 - Sep 13
Form 4
-0.68%
-73.91K
$28.92
-$1.24M
Sep 08, 2021
10.83M
Sale
ScheduledSep 07 - Sep 08
Form 4
0.00%
-119.00
$29.99
-$3.57K
Apr 13, 2021
3.67M
Sale
ScheduledApr 09
Form 4
-0.55%
-40.76K
$31.00
-$777.34K
Apr 09, 2021
7.32M
Sale
ScheduledApr 07 - Apr 08
Form 4
-43.42%
-7.30M
$19.00
$3.04M
Jul 29, 2020
9.51M
Buy-Options
Jul 28
Form 3
Jul 23, 2020
Showing 20 results

Repare Therapeutics Inc.

Investor
Updated Jun 25, 2020
Form 4
9.08%
250.00K
$20.00
Jun 25, 2020
3.00M
Purchase
Jun 23
Form 3
Jun 18, 2020
Showing 2 results

TCR2 THERAPEUTICS INC.

Investor
Updated Jun 05, 2023
Form 4
-100.00%
-4.16M
Jun 05, 2023
Disposition
Jun 01
Form 4
-79.43%
-15.65M
$15.00
Feb 21, 2019
4.05M
Buy-Options
Feb 19
Form 3
Feb 13, 2019
195.90K
Showing 3 results

Werewolf Therapeutics, Inc.

Investor
Updated May 06, 2021
Form 4
-87.99%
-23.36M
$16.00
May 06, 2021
3.19M
Buy-Options
May 04
Form 3
Apr 29, 2021
Showing 2 results

Oncorus, Inc.

Investor
Updated Oct 08, 2020
Form 4
6.49%
173.78K
$15.00
Oct 08, 2020
2.85M
Purchase
Oct 06
Form 3
Oct 01, 2020
115.82K
Showing 2 results